GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » EV-to-Revenue

Neurologix (Neurologix) EV-to-Revenue : (As of May. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Neurologix EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Neurologix's enterprise value is $0.05 Mil. Neurologix's Revenue for the trailing twelve months (TTM) ended in Jun. 2011 was $0.00 Mil. Therefore, Neurologix's EV-to-Revenue for today is .

The historical rank and industry rank for Neurologix's EV-to-Revenue or its related term are showing as below:

NRGXQ's EV-to-Revenue is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.285
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Neurologix's stock price is $1.0E-6. Neurologix's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2011 was $0.00. Therefore, Neurologix's PS Ratio for today is .


Neurologix EV-to-Revenue Historical Data

The historical data trend for Neurologix's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix EV-to-Revenue Chart

Neurologix Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Neurologix Quarterly Data
Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Neurologix's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Neurologix's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurologix's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neurologix's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Neurologix's EV-to-Revenue falls into.



Neurologix EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Neurologix's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.050/0
=

Neurologix's current Enterprise Value is $0.05 Mil.
Neurologix's Revenue for the trailing twelve months (TTM) ended in Jun. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurologix  (GREY:NRGXQ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Neurologix's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.0E-6/0
=

Neurologix's share price for today is $1.0E-6.
Neurologix's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurologix EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Neurologix's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurologix (Neurologix) Business Description

Traded in Other Exchanges
N/A
Address
One Bridge Plaza, Fort Lee, NJ, USA, 07024
Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines